Findings from the SUMMIT, Altshock-2, and FAIR-HF2 trials were presented at the American College of Cardiology 2025 Annual ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

This review discusses the role of aldosterone antagonists in the treatment of heart failure, including an overview of aldosterone’s role in the pathology of heart failure, the benefits of each ...

As the ink dries on the US approval of Novartis' heart failure treatment Entresto, talk has quickly shifted to pricing issues, and possible outcomes-based plans, rather than the drug's very ...

The results of this study suggest that there are specialty-related differences in treatment patterns for CHF patients admitted to our institution. Patient characteristics were similar between ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

This article focuses mainly on systolic CHF and its causes, symptoms, types, and treatment. Fluid builds up in the lungs and causes shortness of breath, even when a person is resting, particularly ...

A gene therapy for heart failure with preserved ejection fraction (HFpEF), also known as diastolic heart failure, has shown ...